ATB Share Price Performance
Recent ATB News & Updates
No updates
Antibiotice S.A. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 14, 2025
- Earnings per share (EPS)
- 0.15
- Gross Margin
- 64.21%
- Net Profit Margin
- 14.63%
- Debt/Equity Ratio
- 22.2%
Antibiotice S.A. Competitors
About ATB
- Founded
- 1955
- Employees
- 1356
- CEO
- WebsiteView website
Antibiotice S.A. produces and sells medicinal products in Romania. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; and veterinary medicines. Its products are available in the form of sterile injectable powders, capsules, tablets, ointments, gels, creams, and suppositories. It also provides active pharmaceutical ingredients. In addition, the company exports its products worldwide. Antibiotice S.A. was founded in 1955 and is headquartered in Iasi, Romania.
Romanian Market Performance
- 7 Days: 1.1%
- 3 Months: 14.0%
- 1 Year: 5.4%
- Year to Date: 12.8%
Over the last 7 days, the market has risen 1.1%, driven by gains of 3.1% in the Energy sector. The market is up 5.4% over the last 12 months. Earnings are forecast to grow by 5.3% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading